The Patent Finder

Neurovive Pharmaceutical AB

Also on record
Records under this name other than patents Neurovive Pharmaceutical AB holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.

Back to Neurovive Pharmaceutical AB

PatentTitleStatus Expires Confidence
US 9,040,487Cyclosporine emulsion
Formerly held
In force
 · From the USPTO record
In forceFrom the USPTO record
US 9,139,613Macrocyclic compounds and methods for their production
Formerly held
In force
 · From the USPTO record
In forceFrom the USPTO record
US 9,119,853Sanglifehrin based compounds
Formerly held
In force
 · From the USPTO record
In forceFrom the USPTO record
US 9,271,977Sanglifehrin derivatives and methods for their production
Formerly held
In force
 · From the USPTO record
In forceFrom the USPTO record
US 9,090,657Compound and methods for its production
Formerly held
In force
 · From the USPTO record
In forceFrom the USPTO record
US 10,307,389Succinate prodrugs for use in the treatment of lactic acidosis or drug-induced side-effects due to Complex I-related impairment of mitochondrial oxidative phosphorylation
Formerly held
In force
 · From the USPTO record
In forceFrom the USPTO record
US 11,147,789Novel Cell-Permeable Succinate Compounds
Formerly held
In force
 · Medium confidence
In forceMedium confidence
US 12,310,940Novel Cell-Permeable Succinate Compounds
Formerly held
In force
 · Medium confidence
In forceMedium confidence
US 9,670,175Protected succinates for enhancing mitochondrial ATP-production
Formerly held
Lapsed on the fee record
Ended Jun 6, 2025 · From the USPTO record
Lapsed on the fee recordEnded Jun 6, 2025From the USPTO record
US 10,857,150Use of sanglifehrin macrocyclic analogues as anticancer compounds
Formerly held
Lapsed on the fee record
Ended Dec 8, 2024 · From the USPTO record
Lapsed on the fee recordEnded Dec 8, 2024From the USPTO record
10 of 17 patents shown.
Pro members see all 17.
Pro members: see all 17 patents
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 18, 2026 · includes USPTO assignment data published Nov 17, 2026, status data published Nov 18, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited